Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2022-12-30 00:00:00 ET · period of report 2022-12-28 · accession 0001437749-22-029955 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-30 | 2022-12-28 | BLFS | Mathew Aby J. | EVP, CSO | S - Sale | $16.90 | -712 | 252.8K | -0.3% | -$12.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-28 | S | D | 712 | $16.90 | 252,826 | D | — | — |